For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230825:nRSY5191Ka&default-theme=true
RNS Number : 5191K Iconic Labs PLC 25 August 2023
25 August 2023
Iconic Labs PLC
("Iconic" or the "Company")
Result of AGM
Iconic Labs PLC (LSE: ICON) is pleased to announce that at the Company's
Annual General Meeting ('AGM') held at 3pm today, all resolutions were duly
passed by way of poll.
At the meeting, inter alia, a resolution was passed which approved the
consolidation of the Company's ordinary shares on a 10,000 for 1 basis, such
that every 10,000 ordinary shares of £0.00001 each were consolidated into 1
ordinary share of £0.1 in nominal value.
As a result, the Company's existing issued share capital of 46,996,580,000
ordinary shares of £0.00001 was consolidated into 4,699,658 ordinary shares
of £0.1, each with one voting right. Admission in respect of such new
ordinary shares will become effective and that dealings in those new ordinary
shares will commence on 30 August 2023. As a result of the consolidation, the
ISIN of the ordinary shares will change from GB00BD060S65 to GB00BRBJ3P08.
The above figure of 4,699,658 should be used by shareholders in the Company as
the denominator for the calculations by which they will determine if they are
required to notify their interest in, or a change to their interest in, the
share capital of the Company under the Financial Conduct Authority's
Disclosure Guidance and Transparency Rules.
The results of the poll were as follows:
Resolutions For % Against % Withheld
1 To receive and adopt the accounts for the financial year ended 30 June 2021. 6,029,829,160 99.02 59,851,506 0.98 89,879,728
2 To receive and adopt the accounts for the financial year ended 30 June 2022. 6,029,829,160 99.02 59,851,506 0.98 89,879,728
3 To re-appoint Norden Audit Limited as Auditors. 6,021,542,347 98.66 81,671,752 1.34 76,346,295
4 To authorise the Directors to determine the remuneration of the Auditors. 6,000,845,301 98.32 102,368,798 1.68 76,346,295
5 To re-appoint Bradley Tyler Taylor as a Director. 6,024,039,929 98.76 75,405,149 1.24 80,115,316
6 To re-appoint David Štýbr as a Director. 6,014,911,904 98.61 84,533,174 1.39 80,115,316
7 To re-appoint Marija Hrebac as a Director. 6,004,365,470 98.44 95,079,608 1.56 80,115,316
8 To re-appoint Emmanuel Blouin as a Director. 5,994,271,904 98.28 105,173,174 1.72 80,115,316
9 Issued ordinary share capital be consolidated and divided into 4,699,658 5,910,559,957 96.84 192,654,142 3.16 76,346,295
ordinary shares of £0.1 each.
10 To authorise the Directors to allot shares up to a maximum aggregate nominal 6,012,800,530 98.52 90,413,569 1.48 76,346,295
amount of £1,905,217.39.
Special Resolutions:
11 To empower the Directors to generally allot relevant equity securities under 6,010,800,530 98.49 92,413,569 1.50 76,346,295
Resolution 10.
12 To authorise the Directors to make market purchases of own shares. 6,039,251,219 98.95 63,962,880 1.04 76,346,295
A vote withheld is not a vote in law and is not counted in the calculation of
the percentage of shares voted for or against any resolution.
- Ends -
For more information, please contact:
Iconic Labs Tel: +44 (0) 7462 156238
Brad Taylor, Chief Executive Officer
Novum Securities Limited Tel: +44 (0) 20 7399 9400
David Coffman / Daniel Harris
Yellow Jersey PR Tel: +44 (0) 20 3004 9512
Sarah Hollins iconic@yellowjerseypr.com
Annabelle Wills
Bessie Elliot
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END RAGPPUMCRUPWGAA